Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Are rapid weight loss drugs hiding the real obesity problem?

Martha Rosenberg
Meds
August 10, 2024
Share
Tweet
Share

According to some academics, in 2019, a ban on junk food advertising across London’s entire public transport network—foods and drinks high in fat and salt and ads for foods–resulted in the prevention of 100,000 obesity cases. Yet the U.S. love affair with the new semaglutide-based weight loss drugs like Ozempic gives junk food advertising and availability a huge pass.

Drug makers and Wall Street are pleased that instead of changing their eating habits, fat people are rushing toward drugs that can be listed at $935.77 per single dose (compute that annually!), raising everyone’s health care costs and taxes from entitlement programs like Medicare. People who don’t overeat are carrying the cost weight, pun intended, along with fat people.

Like Vioxx, reported to have caused between 88,000 and 140,000 cases of serious heart disease and statins linked to diabetes mellitus, liver damage, and cognitive decline, drug makers clearly think they now have a new blockbuster on their hands with the rapid weight loss drugs. In fact, in its day, the medical establishment and public were so enthralled with statins like Lipitor that it was proposed the drug should be put in the drinking water! You can have your bacon cheeseburger with an egg on top and still avoid heart disease, emoted fans. Then the long-term side effects emerged.

But despite efforts from drug makers, the medical establishment, and news outlets with lucrative drug ads to float the new rapid weight loss as dietary saviors addressing a host of problems — they diminish heart risks and addiction, their cheerleaders breathlessly chant––there are serious concerns which will no doubt surface when the blockbuster goes off patent. Surgeons I have interviewed cite life-threatening risks on the operating table from the drugs due to the delayed food digestion they cause. And the drugs are linked to eye risks, negative mental effects, thyroid tumors, pancreatitis, hypoglycemia, gallbladder issues, kidney failure, cancer, and gallbladder conditions requiring hospitalization. Such a deal.

While the drugs’ popularity is driven by vanity among those who overeat and are fat — making it especially popular in Hollywood — it also can cause an ugly, sagging, and old-looking face from the rapid weight loss. (Years ago, supermodels used to say that after a certain age, women had to “choose between their butt and their face” when it came to their appearance.)

As the undesirable side effects emerge as people take the drugs over time––including a rapid gain of weight when the drug is stopped, leading to a de facto “addiction”––will the drugs be so popular in a year or two? Signs suggest no.

Americans have become huge.

The average American man weighs 194 pounds today, and the average woman weighs 165 pounds. Everything from airline seats to coffins to hospital operating tables to amusement park seats has been redesigned to accommodate this gross national product, and its cause is clearly evident.

Look at photos of Americans 20 or 30 years ago, and they have cheekbones, waistlines, and clothes that do not hide their obesity. It’s the food. In addition to ads for fattening, cholesterol- and high fructose-syrup-laden food everywhere, from the TV to commuter train stations, junk food is ubiquitous. It is found in banks, hardware stores, car washes, and even hospitals.

Not only do people wolf down junk food as ads tell them to do, but an insidious movement tells doctors if they mention fat people’s fat, they are “fat shaming.” But obesity causes heart disease, stroke, Type 2 diabetes, fatty liver disease and increases COVID-19 seriousness and is linked to cancers of the uterus, cervix, endometrium, ovary, breast, colon, rectum, esophagus, liver, gallbladder, pancreas, kidney and prostate. There is no such thing as “fit but fat.” If doctors mention a patient’s smoking are they “nicotine shaming”?

The fat acceptance and anti-sizeism movement want the medical profession to enable junk food-related obesity which is especially prevalent in marginalized communities. The move is driven by the politically correct, powerful “woke” movement that says you are not over-eating and fat; you’re a large and big-boned person who is (somehow) born that way. It is not a harmless movement, and doctors should not be silenced. People who do not overeat and are normal-sized pay for the mortality and morbidity of fat people who are told their obesity is not their fault.

While the public, drug makers, the medical establishment, and Wall Street may be enamored with the new rapid weight loss drugs, it is time public health officials address the junk food, junk food advertising, and junk food ubiquity that are behind obesity in the U.S. and elsewhere. It may be making a killing in profits but it is killing its victims.

Martha Rosenberg is a health reporter and the author of Big Food, Big Pharma, Big Lies and Born With a Junk Food Deficiency.  

Prev

A journey of self-worth and healing [PODCAST]

August 9, 2024 Kevin 0
…
Next

Why speaking up in medical school could save lives

August 10, 2024 Kevin 0
…

ADVERTISEMENT

Tagged as: Obesity

Post navigation

< Previous Post
A journey of self-worth and healing [PODCAST]
Next Post >
Why speaking up in medical school could save lives

ADVERTISEMENT

More by Martha Rosenberg

  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Conflicts of interest are eroding trust in U.S. health agencies

    Martha Rosenberg
  • How drug companies turned “depression” into a billion-dollar industry

    Martha Rosenberg

Related Posts

  • Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management

    Dinesh Arab, MD
  • AI’s role in streamlining colorectal cancer screening [PODCAST]

    The Podcast by KevinMD
  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • Pandemic aftermath: Navigating a new normal in health, education, and social dynamics

    Susan Levenstein, MD
  • Medicare’s 14-day rule is hurting cancer patients

    Sean Jordan, MD
  • How weight loss drugs are creating a medical dilemma

    Yasmine Kamgarhaghighi

More in Meds

  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • The food-drug interaction risks your doctor may be missing

    Frank Jumbe
  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • 5 blind spots that stall physician wealth

      Johnny Medina, MSc | Finance
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • 5 blind spots that stall physician wealth

      Johnny Medina, MSc | Finance
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • Why flashy AI tools won’t fix health care without real infrastructure

      David Carmouche, MD | Tech
  • Recent Posts

    • Why judgment is hurting doctors—and how mindfulness can heal

      Jessie Mahoney, MD | Physician
    • Why medical schools must ditch lectures and embrace active learning

      Arlen Meyers, MD, MBA | Education
    • Why helping people means more than getting an MD

      Vaishali Jha | Education
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • Why evidence-based management may be an effective strategy for stronger health care leadership and equity

      Olumuyiwa Bamgbade, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...